Please login to the form below

Ashfield Healthcare Communications rebrands as Ashfield Health

Ashfield Health, part of UDG Healthcare plc, announces transformational changes including the unveiling of a new Global President, a rebrand, and the launch of two new global agencies.

Ashfield Healthcare Communications rebrands as Ashfield Health, launches two new global agencies and appoints former McCann Health Americas head as Global President.

  • Former 19-year McCann Health veteran, latterly President of the Americas, Amar Urhekar, joins as Global President of the >1,450 people-strong Ashfield Health network.
  • Ashfield Digital and Creative (UK), Cambridge BioMarketing (US) and Pegasus (UK) merge to form Mind+Matter, a new global, data-driven creative communications agency.
  • Ashfield Health’s 14 medical and scientific communications agencies come together to create Ashfield MedComms, a new 700 strong global powerhouse.
  • Ashfield Health agencies unified by common brand identity and shared new purpose to ‘make it matter’

Following a healthcare communications career spanning over two decades of leadership in five countries, Amar Urhekar takes the helm as Global President of the >1,450 strong network that is rebranding from Ashfield Healthcare Communications to Ashfield Health. Since joining, Amar Urhekar has led the network through the challenges of COVID-19, resulting in continued growth, and has put a new strategy in place, which sees Ashfield Health emerge as a new agile, dynamic network – data and technology driven, creative, and diverse.

Ashfield Health is now designed to respond better and quicker to the new challenges our clients face. We encourage independence and entrepreneurialism in our specialist agency teams but also have the unique ability to work as one team when needed. By unifying around our common purpose of make it matter, we have stronger connections that enable us to scale rapidly and provide our clients with tailored expert teams. We can truly deliver life-changing work that matters,” said Amar Urhekar, Global President of Ashfield Health.

Central to Ashfield Health’s new strategy has been a merging of some of the network’s standout acquisitions from the past 10 years to form two exciting new global agencies - Mind+Matter and Ashfield MedComms.

Mind+Matter is a new 250-strong global creative communications agency that creates meaningful experiences by bringing data and emotion together to drive behavior change. Formed through the merging of three successful Ashfield Health agencies – US-based Cambridge BioMarketing, UK-based Ashfield Digital and Creative and Pegasus – Mind+Matter will span the breadth of health from consumer health through to established pharma and rare and novel therapies. Mind+Matter will be led by former President of Cambridge BioMarketing, Ben Beckley.

“We’re already using data and descriptive analytics to predict behaviour before it happens, but Mind+Matter will be breaking new ground by significantly investing in new data talent and technology and combining this with emotionally powerful creativity. By bringing these three individual agencies together, we have built a new team that can operate globally and uniquely apply this across the full spectrum of health – a perfect example of how Ashfield Health is answering the big challenges our clients have,” comments Urhekar.

Ashfield MedComms brings together over 700 creatives, scientists, strategists, and client partnersto form one of the largest scientific and medical communications agencies in the world. Ashfield MedComms’ work will continue to span new medicines for diseases where no treatment existed, to paradigm-shifting advances, to precision medicines, real-world evidence and patient-relevant outcomes, to technologies and diagnostics.This new global powerhouse will be headed up by regional Ashfield Health Presidents Richard Lawrence (International) and Matt Jacobson (North America), reporting into Amar Urhekar.

“The scientific strength and leadership in our individual agencies has been built over decades, but the creation of Ashfield MedComms signals our ability to evolve for today. By bringing our agencies together and investing heavily in strategic and creative talent, our clients will have a unrivalled global partner that can help them play a bigger role in shaping the future of healthcare and ultimately patient’s lives,” said Urhekar.

The Ashfield Health network has grown rapidly in recent years following a series of select – specialist acquisitions, including CanaleComms, CreateNYC, Galliard, Incisive Health, and MicroMass in addition to the former Cambridge BioMarketing and Pegasus agencies.  All Ashfield Health agencies are united by a new brand identity and shared purpose to make it matter.

“Central to connecting this great network of agencies is a shared purpose,” explains Urhekar.  “Our drive to ‘make it matter’ inspires us to grow, adapt, be more creative and work smarter than anyone else to deliver work that is truly life changing.From making discoveries to making a difference, we will take every opportunity to challenge convention and spark change for better health – this is something that you will see in every Ashfield Health agency.”

The new strategy has seen several new positions created to support capability development, growth and innovation – an example of this is the appointment of former Business Unit Head with responsibility for Ashfield Digital and Creative and Pegasus, Simon Hackett, into the role of Global Growth Director, Ashfield Health.

Visit to find out more

2nd February 2021



Company Details

Evoke Mind+Matter

+44 (0)1273 712000

Contact Website

Sovereign House
Church Street
East Sussex

Latest content on this profile

Personalized Oncology: Calling for a New Kind of Partnership:
In the 1990s, biomarkers were the future of personalized medicine and a “lab on a chip” was the holy grail of understanding patient health. As much as past predictions of whole organ transplants and intra-body cameras have been realized, the notion of using measuring an array of protein to better understand a patient’s individual health, current and future, has still eluded us. But maybe for not much longer.
Evoke Mind+Matter
*Corrina Safeio, promoted to Group Managing Director taking on responsibility for Evoke London and Evoke Mind+Matter *Lee Wales, promoted to Deputy Managing Director at Evoke Mind+Matter UK *Holly Ford, promoted to Head of Consumer Communications at Evoke Mind+Matter UK
Evoke Mind+Matter
*Mohinder Mann joins as Associate Medical Director *Nicole Moores joins as Associate Director, Pharma & Lifesciences *Sharron Woods joins as Associate Director, Animal Health Evoke Mind+Matter has continued to strengthen its global marcomms offering with the addition of three strategic associate level hires.
Evoke Mind+Matter
Headed up by Research Director, Angela McMean, the Evoke Mind+Matter Insights division comprises a team of primary research specialists focused on delivering meaningful, data-driven insight that supports the agency’s mission to drive measurable behaviour change.
Evoke Mind+Matter
*Mind+Matter closes its first year of business celebrating more than £4 million of new business wins in the UK *The global agency launched in Jan 21 has also been awarded a ‘Communique’ award for ‘Excelling in multi-channel campaigns’ for its work with CSL Behring, alongside six further award commendations and wins  *The agency offers a ‘health first, sector second’ approach with access to sector experts with unparalleled breadth and depth of capabilities *The growth has led to more than 60 new hires globally, and senior promotions to the UK leadership team alongside the launch of - a first of its kind global healthcare intelligence data platform
Evoke Mind+Matter
Dynamic data-driven solution unlocks deeper insights and powers stronger omnichannel experiences.
Evoke Mind+Matter